Lung Cancer Screening: Subsequent Evidences of National Lung Screening Trial
°áÇÙ¹×È£Èí±âÁúȯ 2014³â 77±Ç 2È£ p.55 ~ p.59
¹Ú¿µ½Ä(Park Young-Sik) - Seoul National University Hospital Department of Internal Medicine
Abstract
The US National Lung Screening Trial (NLST) demonstrated a 20% reduction in lung cancer mortality and a 6.7% decrease in all-cause mortality. The NLST is the only trial showing positive results in a high-risk population, such as in patients with old age and heavy ever smokers. Lung cancer screening using a low-dose chest computed tomography might be beneficial for the high-risk group. However, there may also be potential adverse outcomes in terms of over diagnosis, bias and cost-effectiveness. Until now, lung cancer screening remains controversial. In this review, we wish to discuss the evolution of lung cancer screening and summarize existing evidences and recommendations.
Å°¿öµå
Lung Neoplasms, Early Detection of Cancer, Tomography, X-Ray Computed, Thorax
KMID :
0383820140770020055
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)